to BioTechniques free email alert service to receive content updates.
Cell Culture
Disease-specific iPS cell lines
Coriell Institute for Medical Research's induced pluripotent stem (iPS) cells lines were derived from individuals with Huntington’s disease, juvenile onset diabetes, muscular dystrophy, spinal muscular atrophy, or severe combined immunodeficiency.
Coriell Institute for Medical Research's induced pluripotent stem (iPS) cells lines were derived from individuals with Huntington’s disease, juvenile onset diabetes, muscular dystrophy, spinal muscular atrophy, or severe combined immunodeficiency. These cell lines are available through the National Institutes of General Medical Sciences (NIGMS) Human Genetic Cell Repository at Coriell.
 
This Product is made by:

Coriell Institute for Medical Research is an independent, non-profit biomedical research institution based in Camden, New Jersey. Founded in 1953, the Institute is dedicated to unlocking the genetic code of human disease. Coriell is a pioneer in genomic medicine, examining the utility of DNA information in clinical care through the Coriell Personalized Medicine Collaborative (CPMC) research study (www.cpmc.coriell.org). Coriell is also exploring the promise of induced pluripotent stem cells – stem cells created from skin or blood – having the potential to advance today’s understanding of human disease. And, Coriell continues to be recognized as the world’s leading biobank, distributing biological samples, and offering custom research services, to scientists around the globe. For more, visit www.coriell.org.